Related Experiment Video
Updated: May 7, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Retrospective outcomes of glucose control in critically ill children
Sarah B Kandil1, Debra Spear, Neal J Thomas
1Department of Pediatrics, Section of Pediatric Critical Care Medicine, Yale University School of Medicine, 333 Cedar St., P.O. Box 208064, New Haven, CT 06520-8064. sarah.kandil@yale.edu.
Insights
Controlling high blood glucose (BG) in critically ill children with insulin did not improve outcomes and was associated with fewer intensive care unit (ICU)-free days. Further randomized trials are needed to clarify glucose control benefits.
Area of Science:
- Pediatric Critical Care Medicine
- Endocrinology
- Metabolic Disorders
Background:
- Hyperglycemia is a common and concerning issue in critically ill children.
- Current treatment strategies for hyperglycemia in this population lack consensus.
- This study investigates the impact of blood glucose control interventions.
Purpose of the Study:
- To evaluate the effect of insulin therapy for hyperglycemia on outcomes in critically ill children.
- To compare outcomes between hyperglycemic children receiving insulin and those not receiving interventions.
Main Methods:
- Retrospective cohort study comparing a treatment group (insulin for BG ≥ 150 mg/dl) with a historical baseline group.
- Included nondiabetic critically ill children requiring mechanical ventilation and/or vasopressors.
- Analyzed intensive care unit (ICU)-free days, ventilator-free days, vasopressor-free days, and mortality.
Main Results:
- The treatment group (n=130) had lower mean BG (140 mg/dl) than the baseline group (n=137, 179 mg/dl).
- The treatment group experienced 2.5 fewer ICU-free days (p=.023) after adjustment.
- No significant association found between glucose control and ICU stay duration, ventilator/vasopressor-free days, or mortality.
Conclusions:
- Blood glucose control in critically ill children may be associated with adverse outcomes.
- Conflicting evidence from adult studies necessitates caution.
- Strong recommendation for randomized controlled trials to definitively assess glucose control efficacy in pediatric critical care.
Background:
Hyperglycemia is a significant problem for critically ill children. Treatment for hyperglycemia remains controversial. This study explores the effect of controlling blood glucose (BG) in hyperglycemic critically ill children.
Methods:
A retrospective cohort of nondiabetic critically ill children (defined as requiring mechanical ventilation and/or vasopressors) with BG persistently ≥ 150 mg/dl and treated with insulin (treatment group) were compared with a historical cohort of similar children who did not receive interventions to control hyperglycemia (baseline group).
Results:
There were 130 children in the treatment group and 137 children in the baseline group. Mean BG in the treatment group was 140 ± 24 mg/dl compared with 179 ± 47 mg/dl in the baseline group (p < .001). After adjusting for patient characteristics, cointerventions, and glucose metrics, patients in the treatment group had 2.5 fewer intensive care unit (ICU)-free days (i.e., number of days alive and discharged from ICU within 28 days after inclusion) than the baseline group (p = .023). Glucose control was not independently associated with duration of ICU stay, ventilator-free days, vasopressor-free days, or mortality.
Conclusions:
Blood glucose control appears associated with worse outcomes in critically ill children. Our data combined with conflicting results in adults leads us to strongly advocate for the conduct of randomized trials on glucose control in critically ill children.
Related Concept Videos
Hyperglycemia
Hypoglycemia and Glucagon
Diabetes Mellitus: Type 2 and Gestational
Hypoglycemia
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes: Symptoms, Diagnosis, and Complications

